-
1
-
-
0035952364
-
Thyroid cancer
-
Gimm O. Thyroid cancer. Cancer Lett. 2001;163:143-156.
-
(2001)
Cancer Lett
, vol.163
, pp. 143-156
-
-
Gimm, O.1
-
2
-
-
17744412728
-
Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996
-
Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. Cancer. 2000;89:202-217.
-
(2000)
Cancer
, vol.89
, pp. 202-217
-
-
Hundahl, S.A.1
Cady, B.2
Cunningham, M.P.3
-
3
-
-
0003304784
-
Pathology of thyroid gland
-
Livolsi VA, Asa SL, eds. New York: Churchill Livingstone
-
Baloch ZW, LiVolsi VA. Pathology of thyroid gland. In: Livolsi VA, Asa SL, eds. Endocrine Pathology. New York: Churchill Livingstone, 2002: 61-88.
-
(2002)
Endocrine Pathology
, pp. 61-88
-
-
Baloch, Z.W.1
Livolsi, V.A.2
-
5
-
-
0036269450
-
Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions
-
Hermann ME, LiVolsi VA, Pasha TL, et al. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. Arch Pathol Lab Med. 2002;126:710-713.
-
(2002)
Arch Pathol Lab Med
, vol.126
, pp. 710-713
-
-
Hermann, M.E.1
Livolsi, V.A.2
Pasha, T.L.3
-
6
-
-
0037003325
-
The meanings of markers: Ancillary techniques in diagnosis of thyroid neoplasia
-
Raphael SJ. The meanings of markers: ancillary techniques in diagnosis of thyroid neoplasia. Endocrinol Pathol. 2002;13:301-311.
-
(2002)
Endocrinol Pathol
, vol.13
, pp. 301-311
-
-
Raphael, S.J.1
-
7
-
-
0036042779
-
Cytokeratin 19 and galcctin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules
-
Beesley MF, McLaren KM. Cytokeratin 19 and galcctin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Histopathology. 2002;41:236-243.
-
(2002)
Histopathology
, vol.41
, pp. 236-243
-
-
Beesley, M.F.1
McLaren, K.M.2
-
8
-
-
0034495038
-
Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: Possible relation to tumor progression
-
Cvejic D, Savin S, Golubovic S, et al. Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumor progression. Histopathology. 2000;37:530-535.
-
(2000)
Histopathology
, vol.37
, pp. 530-535
-
-
Cvejic, D.1
Savin, S.2
Golubovic, S.3
-
9
-
-
10744223468
-
Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry
-
Feilchenfeldt J, Totsch M, Sheu SY, et al. Expression of galectin-3 in normal and malignant thyroid tissue by quantitative PCR and immunohistochemistry. Mod Pathol. 2003;16:1117-1123.
-
(2003)
Mod Pathol
, vol.16
, pp. 1117-1123
-
-
Feilchenfeldt, J.1
Totsch, M.2
Sheu, S.Y.3
-
10
-
-
0036156211
-
Galectiu-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia
-
Coli A, Bigotti G, Zucchetti F, et al. Galectiu-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology. 2002;40:80-87.
-
(2002)
Histopathology
, vol.40
, pp. 80-87
-
-
Coli, A.1
Bigotti, G.2
Zucchetti, F.3
-
11
-
-
0035954068
-
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
-
Bartolazzi A, Gasbarri A, Papotti M, et al. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet. 2001;357:1644-1650.
-
(2001)
Lancet
, vol.357
, pp. 1644-1650
-
-
Bartolazzi, A.1
Gasbarri, A.2
Papotti, M.3
-
12
-
-
0035181926
-
Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma
-
Saggiorato E, Cappia S, De Giuli P, et al. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab. 2001;86:5152-5158.
-
(2001)
J Clin Endocrinol Metab
, vol.86
, pp. 5152-5158
-
-
Saggiorato, E.1
Cappia, S.2
De Giuli, P.3
-
14
-
-
0036225260
-
E-cadherin expression in follicular carcinoma of the thyroid
-
Kato N, Tsuchiya T, Tamura G, et al. E-cadherin expression in follicular carcinoma of the thyroid. Pathol Int. 2002;52:13-18.
-
(2002)
Pathol Int
, vol.52
, pp. 13-18
-
-
Kato, N.1
Tsuchiya, T.2
Tamura, G.3
-
15
-
-
0032752971
-
Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules
-
Gasbarri A, Martegani MP, Del Prete F, et al. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol. 1999;17:3494-3502.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3494-3502
-
-
Gasbarri, A.1
Martegani, M.P.2
Del Prete, F.3
-
16
-
-
0027065573
-
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons
-
Screaton GR, Bell MV, Jackson DJ, et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci USA. 1992;89:12160-12164.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 12160-12164
-
-
Screaton, G.R.1
Bell, M.V.2
Jackson, D.J.3
-
17
-
-
0031767144
-
Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma
-
Kurozumi K, Nakao K, Nishida T, et al. Significance of biologic aggressiveness and proliferating activity in papillary thyroid carcinoma. World J Surg. 1998;22:1237-1242.
-
(1998)
World J Surg
, vol.22
, pp. 1237-1242
-
-
Kurozumi, K.1
Nakao, K.2
Nishida, T.3
-
19
-
-
3543124251
-
CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer
-
Bendardaf R, Lamlum H, Ristamaki R, et al. CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer. Oncol Rep. 2004;11:41-45.
-
(2004)
Oncol Rep
, vol.11
, pp. 41-45
-
-
Bendardaf, R.1
Lamlum, H.2
Ristamaki, R.3
-
20
-
-
0242526960
-
Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas
-
Rodrigo JP, Dominguez F, Alvarez C, et al. Expression of E-cadherin, CD44s, and CD44v6 in laryngeal and pharyngeal carcinomas. Am J Otolaryngol. 2003;24:384-389.
-
(2003)
Am J Otolaryngol
, vol.24
, pp. 384-389
-
-
Rodrigo, J.P.1
Dominguez, F.2
Alvarez, C.3
-
21
-
-
0141920758
-
Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung
-
Ruibal A, Nunez MI, Rodriguez J, et al. Cytosolic levels of neuron-specific enolase in squamous cell carcinomas of the lung. Int J Biol Markers. 2003;18:188-194.
-
(2003)
Int J Biol Markers
, vol.18
, pp. 188-194
-
-
Ruibal, A.1
Nunez, M.I.2
Rodriguez, J.3
-
22
-
-
0031948876
-
Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells
-
Gu J, Daa T, Kashima K, et al. Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells. Pathol Int. 1998;48:184-190.
-
(1998)
Pathol Int
, vol.48
, pp. 184-190
-
-
Gu, J.1
Daa, T.2
Kashima, K.3
-
23
-
-
0028672288
-
Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma
-
Figge J, del Rosario AD, Gerasimov G, et al. Preferential expression of the cell adhesion molecule CD44 in papillary thyroid carcinoma. Exp Mol Pathol. 1994;61:203-211.
-
(1994)
Exp Mol Pathol
, vol.61
, pp. 203-211
-
-
Figge, J.1
Del Rosario, A.D.2
Gerasimov, G.3
-
24
-
-
0036073661
-
Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma
-
Kim J, Cho H, Rhee B, et al. Expression of CD44 and cyclin D1 in fine needle aspiration cytology of papillary thyroid carcinoma. Acta Cytol. 2002;46:679-683.
-
(2002)
Acta Cytol
, vol.46
, pp. 679-683
-
-
Kim, J.1
Cho, H.2
Rhee, B.3
-
25
-
-
0031873396
-
Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma
-
Resnick MB, Schacter P, Finkelstein Y, et al. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma. Mod Pathol. 1998;11:735-739.
-
(1998)
Mod Pathol
, vol.11
, pp. 735-739
-
-
Resnick, M.B.1
Schacter, P.2
Finkelstein, Y.3
-
26
-
-
0031788262
-
The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis
-
Wang S, Wuu J, Savas L, et al. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis. Hum Pathol. 1998;29:1304-1309.
-
(1998)
Hum Pathol
, vol.29
, pp. 1304-1309
-
-
Wang, S.1
Wuu, J.2
Savas, L.3
-
27
-
-
0033626268
-
P27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma
-
Erickson LA, Yousef OM, Jin L, et al. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma. Mod Pathol. 2000;13:1014-1019.
-
(2000)
Mod Pathol
, vol.13
, pp. 1014-1019
-
-
Erickson, L.A.1
Yousef, O.M.2
Jin, L.3
-
28
-
-
0031912856
-
Apoptosis in thyroid neoplasms: Relationship with p53 and bcl-2 expression
-
Moore D, Ohene-Fianko D, Garcia B, et al. Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression. Histopathology. 1998;32:35-42.
-
(1998)
Histopathology
, vol.32
, pp. 35-42
-
-
Moore, D.1
Ohene-Fianko, D.2
Garcia, B.3
-
29
-
-
0035678388
-
Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma
-
Wang S, Lloyd RV, Hutzler MJ, et al. Expression of eukaryotic translation initiation factors 4E and 2alpha correlates with the progression of thyroid carcinoma. Thyroid. 2001;11:1101-1107.
-
(2001)
Thyroid
, vol.11
, pp. 1101-1107
-
-
Wang, S.1
Lloyd, R.V.2
Hutzler, M.J.3
-
30
-
-
0028040051
-
Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas
-
Dobashi Y, Sugimura H, Sakamoto A, et al. Stepwise participation of p53 gene mutation during dedifferentiation of human thyroid carcinomas. Diagn Mol Pathol. 1994;3:9-14.
-
(1994)
Diagn Mol Pathol
, vol.3
, pp. 9-14
-
-
Dobashi, Y.1
Sugimura, H.2
Sakamoto, A.3
-
31
-
-
0029926953
-
Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer
-
Nishida T, Nakao K, Hamaji M, et al. Overexpression of p53 protein and DNA content are important biologic prognostic factors for thyroid cancer. Surgery. 1996;119:568-575.
-
(1996)
Surgery
, vol.119
, pp. 568-575
-
-
Nishida, T.1
Nakao, K.2
Hamaji, M.3
-
32
-
-
0028967830
-
Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis
-
Bartkova J, Lukas J, Strauss M, et al. Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis. Oncogene. 1995;10: 775-778.
-
(1995)
Oncogene
, vol.10
, pp. 775-778
-
-
Bartkova, J.1
Lukas, J.2
Strauss, M.3
-
33
-
-
0033889242
-
The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer
-
Wang S, Lloyd RV, Hutzler MJ, et al. The role of cell cycle regulatory protein, cyclin D1, in the progression of thyroid cancer. Mod Pathol. 2000;13:882-887.
-
(2000)
Mod Pathol
, vol.13
, pp. 882-887
-
-
Wang, S.1
Lloyd, R.V.2
Hutzler, M.J.3
-
34
-
-
0036277917
-
Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma
-
Khoo ML, Beasley NJ, Ezzat S, et al. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2002;87:1814-1818.
-
(2002)
J Clin Endocrinol Metab
, vol.87
, pp. 1814-1818
-
-
Khoo, M.L.1
Beasley, N.J.2
Ezzat, S.3
-
35
-
-
0031594658
-
Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors
-
Erickson LA, Jin L, Wollan PC, et al. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Mod Pathol. 1998;11:169-174.
-
(1998)
Mod Pathol
, vol.11
, pp. 169-174
-
-
Erickson, L.A.1
Jin, L.2
Wollan, P.C.3
-
36
-
-
0344236251
-
Superficial radiotherapy for patients with basal cell carcinoma: Recurrence rates, histologic subtypes, and expression of p53 and Bcl-2
-
Zagrodnik B, Kempf W, Seifert B, et al. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer. 2003;98:2708-2714.
-
(2003)
Cancer
, vol.98
, pp. 2708-2714
-
-
Zagrodnik, B.1
Kempf, W.2
Seifert, B.3
-
37
-
-
0345098484
-
Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes
-
Arun B, Kilic G, Yen C, et al. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Cancer. 2003;98:2554-2559.
-
(2003)
Cancer
, vol.98
, pp. 2554-2559
-
-
Arun, B.1
Kilic, G.2
Yen, C.3
-
38
-
-
33645488245
-
Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: A clinicopathologic study
-
Scopa CD, Tsamandas AC, Zolota V, et al. Potential role of bcl-2 and ki-67 expression and apoptosis in colorectal carcinoma: a clinicopathologic study. Cancer. 2003;98:2554-2559.
-
(2003)
Cancer
, vol.98
, pp. 2554-2559
-
-
Scopa, C.D.1
Tsamandas, A.C.2
Zolota, V.3
-
39
-
-
0037530398
-
Expression of the bcl-2 gene and its significance in human pancreatic carcinoma
-
Sun CY, Wang BL, Hu CQ, et al. Expression of the bcl-2 gene and its significance in human pancreatic carcinoma. Hepatobiliary Pancreat Dis Int. 2002;1:306-308.
-
(2002)
Hepatobiliary Pancreat Dis Int
, vol.1
, pp. 306-308
-
-
Sun, C.Y.1
Wang, B.L.2
Hu, C.Q.3
-
40
-
-
0031818696
-
Expression of bcl-2 and p53 in oncoeytic tumors of the thyroid: An immunohistochemical study
-
Kohli A, Baker S, Patwardhan N, et al. Expression of bcl-2 and p53 in oncoeytic tumors of the thyroid: an immunohistochemical study. Endocr Pathol. 1998;9:117-123.
-
(1998)
Endocr Pathol
, vol.9
, pp. 117-123
-
-
Kohli, A.1
Baker, S.2
Patwardhan, N.3
-
41
-
-
0028174254
-
Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland
-
Pilotti S, Collini P, Rilke F, et al. bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol. 1994;172:337-342.
-
(1994)
J Pathol
, vol.172
, pp. 337-342
-
-
Pilotti, S.1
Collini, P.2
Rilke, F.3
-
42
-
-
0039656540
-
Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis
-
Rosenwald IB, Chen J, Wang S, et al. Upregulation of protein synthesis initiation factor eIF-4E is an early event during colon carcinogenesis. Oncogens. 1999;18:2507-2517.
-
(1999)
Oncogens
, vol.18
, pp. 2507-2517
-
-
Rosenwald, I.B.1
Chen, J.2
Wang, S.3
-
43
-
-
0033031044
-
Expression of the eukaryotic initiation factors 4E and 2a in non-Hodgkin's lymphomas
-
Wang S, Rosenwald IB, Hutzler MJ, et al. Expression of the eukaryotic initiation factors 4E and 2a in non-Hodgkin's lymphomas. Am J Pathol. 1999;155:247-255.
-
(1999)
Am J Pathol
, vol.155
, pp. 247-255
-
-
Wang, S.1
Rosenwald, I.B.2
Hutzler, M.J.3
-
44
-
-
0035159952
-
Cytokeratin expression profiles in thyroid carcinomas
-
Lam KY, Lui MC, Lo CY. Cytokeratin expression profiles in thyroid carcinomas. Eur J Surg Oncol. 2001;27:631-635.
-
(2001)
Eur J Surg Oncol
, vol.27
, pp. 631-635
-
-
Lam, K.Y.1
Lui, M.C.2
Lo, C.Y.3
-
45
-
-
0035735719
-
Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: A note of caution
-
Sahoo S, Hoda SA, Rosai J, et al. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. Am J Clin Pathol. 2001;116:696-702.
-
(2001)
Am J Clin Pathol
, vol.116
, pp. 696-702
-
-
Sahoo, S.1
Hoda, S.A.2
Rosai, J.3
-
46
-
-
0028419001
-
High-molecular-weight cytokeratin and CK-19 in the diagnosis of thyroid tumors
-
Raphael SJ, McKeown-Eyssen G, Asa SL. High-molecular-weight cytokeratin and CK-19 in the diagnosis of thyroid tumors. Mod Pathol. 1994;7:295-300.
-
(1994)
Mod Pathol
, vol.7
, pp. 295-300
-
-
Raphael, S.J.1
McKeown-Eyssen, G.2
Asa, S.L.3
-
47
-
-
0023142495
-
Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue
-
Henzen-Logmans SC, Mullink H, Ramaekers FC, et al. Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue. Virchows Arch A Pathol Anal Histopathol. 1987;410:347-354.
-
(1987)
Virchows Arch a Pathol Anal Histopathol
, vol.410
, pp. 347-354
-
-
Henzen-Logmans, S.C.1
Mullink, H.2
Ramaekers, F.C.3
-
48
-
-
0023508140
-
Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas
-
Dockhorn-Dworniczak B, Franke WW, Schroder S, et al. Patterns of expression of cytoskeletal proteins in human thyroid gland and thyroid carcinomas. Differentiation. 1987;35:53-71.
-
(1987)
Differentiation
, vol.35
, pp. 53-71
-
-
Dockhorn-Dworniczak, B.1
Franke, W.W.2
Schroder, S.3
-
49
-
-
0033840468
-
Thyroid transcription factor-1, thyroglobulin, eytokeratin 7, and cytokeratin 20 in thyroid neoplasms
-
Bejarano PA, Nikiforov YE, Swenson ES, et al. Thyroid transcription factor-1, thyroglobulin, eytokeratin 7, and cytokeratin 20 in thyroid neoplasms. Appl Immunohistochem Mol Morphol. 2000;8:189-194.
-
(2000)
Appl Immunohistochem Mol Morphol
, vol.8
, pp. 189-194
-
-
Bejarano, P.A.1
Nikiforov, Y.E.2
Swenson, E.S.3
-
50
-
-
0030943220
-
Pattern of expression of intermediate eytokeratin filaments in the thyroid gland: An immunohistochemical study of simple and stratified epithelial-type cytokeratins
-
Fonseca E, Nesland JM, Hoie J, et al. Pattern of expression of intermediate eytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch. 1997;430:239-245.
-
(1997)
Virchows Arch
, vol.430
, pp. 239-245
-
-
Fonseca, E.1
Nesland, J.M.2
Hoie, J.3
-
51
-
-
0034857448
-
Immunostaining for RET oncogene proteins in papillary thyroid carcinoma: A correlation of RET immunoreactivity and potential of lymph node metastasis
-
Mai KT, Vaccani JP, Thomas J, et al. Immunostaining for RET oncogene proteins in papillary thyroid carcinoma: a correlation of RET immunoreactivity and potential of lymph node metastasis. Thyroid. 2001;11: 859-863.
-
(2001)
Thyroid
, vol.11
, pp. 859-863
-
-
Mai, K.T.1
Vaccani, J.P.2
Thomas, J.3
-
52
-
-
0036087007
-
Molecular rearrangements and morphology in thyroid cancer
-
Kroll TG. Molecular rearrangements and morphology in thyroid cancer. Am J Pathol. 2002;160:1941-1944.
-
(2002)
Am J Pathol
, vol.160
, pp. 1941-1944
-
-
Kroll, T.G.1
-
53
-
-
0242285636
-
Molecular mutations in thyroid carcinogencsis
-
Hunt JL. Molecular mutations in thyroid carcinogencsis. Am J Clin Pathol. 2002;118(Suppl):S116-S127.
-
(2002)
Am J Clin Pathol
, vol.118
, Issue.SUPPL.
-
-
Hunt, J.L.1
-
54
-
-
0035984201
-
PAX8-PPAR gamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses
-
Nikiforova MN, Biddinger PW, Caudill CM, et al. PAX8-PPAR gamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses. Am J Surg Pathol. 2002;26:1016-1023.
-
(2002)
Am J Surg Pathol
, vol.26
, pp. 1016-1023
-
-
Nikiforova, M.N.1
Biddinger, P.W.2
Caudill, C.M.3
-
55
-
-
85047687789
-
Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies
-
Gustafson KS, LiVolsi VA, Furth EE, et al. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies. Am J Clin Pathol. 2003;120:175-181.
-
(2003)
Am J Clin Pathol
, vol.120
, pp. 175-181
-
-
Gustafson, K.S.1
Livolsi, V.A.2
Furth, E.E.3
-
56
-
-
0345268763
-
Genetic and biological subgroups of low-stage follicular thyroid cancer
-
French CA, Alexander EK, Cibas ES, et al. Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol. 2003; 162:1053-1060.
-
(2003)
Am J Pathol
, vol.162
, pp. 1053-1060
-
-
French, C.A.1
Alexander, E.K.2
Cibas, E.S.3
-
57
-
-
0035889953
-
Karyotypic characterization of papillary thyroid carcinomas
-
Roque L, Nunes VM, Ribeiro C, et al. Karyotypic characterization of papillary thyroid carcinomas. Cancer. 2001;92:2529-2538.
-
(2001)
Cancer
, vol.92
, pp. 2529-2538
-
-
Roque, L.1
Nunes, V.M.2
Ribeiro, C.3
-
58
-
-
0035045841
-
Immunohistochemical diagnosis of papillary thyroid carcinoma
-
Cheung CC, Ezzat S, Freeman JL, et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. Mod Pathol. 2001;14:338-342.
-
(2001)
Mod Pathol
, vol.14
, pp. 338-342
-
-
Cheung, C.C.1
Ezzat, S.2
Freeman, J.L.3
-
59
-
-
0035108299
-
Beta-catenin dysregulation in thyroid neoplasms: Down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis
-
Garcia-Rostan G, Camp RL, Herrero A, et al. Beta-catenin dysregulation in thyroid neoplasms: down-regulation, aberrant nuclear expression, and CTNNB1 exon 3 mutations are markers for aggressive tumor phenotypes and poor prognosis. Am J Pathol. 2001;158:987-996.
-
(2001)
Am J Pathol
, vol.158
, pp. 987-996
-
-
Garcia-Rostan, G.1
Camp, R.L.2
Herrero, A.3
-
60
-
-
0033561515
-
Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma
-
Garcia-Rostan G, Tallini G, Herrero A, et al. Frequent mutation and nuclear localization of beta-catenin in anaplastic thyroid carcinoma. Cancer Res. 1999;59:1811-1815
-
(1999)
Cancer Res
, vol.59
, pp. 1811-1815
-
-
Garcia-Rostan, G.1
Tallini, G.2
Herrero, A.3
-
61
-
-
33645493093
-
-
Presented at U.S. and Canadian Academy of Pathology, Washington DC, March
-
Rezk S, Fischer A, Nelson V, et al. β-catcnin expression in papillary thyroid carcinoma: potential role in nuclear envelope changes. Presented at U.S. and Canadian Academy of Pathology, Washington DC, March 2003.
-
(2003)
β-Catcnin Expression in Papillary Thyroid Carcinoma: Potential Role in Nuclear Envelope Changes
-
-
Rezk, S.1
Fischer, A.2
Nelson, V.3
-
62
-
-
0036164623
-
Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hurthle cell and/or apocrine-like changes
-
Mai KT, Bokhary R, Yazdi HM, et al. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hurthle cell and/or apocrine-like changes. Histopathology. 2002;40:133-142.
-
(2002)
Histopathology
, vol.40
, pp. 133-142
-
-
Mai, K.T.1
Bokhary, R.2
Yazdi, H.M.3
-
63
-
-
0026581795
-
Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma
-
Sheibani K, Esteban JM, Bailey A, et al. Immunopathologic and molecular studies as an aid to the diagnosis of malignant mesothelioma. Hum Pathol. 1992;23:107-116.
-
(1992)
Hum Pathol
, vol.23
, pp. 107-116
-
-
Sheibani, K.1
Esteban, J.M.2
Bailey, A.3
-
64
-
-
0038529696
-
Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1
-
Casey MB, Lohse CM, Lloyd RV. Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin-3, and HBME-1. Endocrinol Pathol. 2003;14:55-60.
-
(2003)
Endocrinol Pathol
, vol.14
, pp. 55-60
-
-
Casey, M.B.1
Lohse, C.M.2
Lloyd, R.V.3
-
65
-
-
0035106490
-
HBME-1 immunostaining in thyroid pathology
-
Rigau V, Martel B, Evrard C, et al. HBME-1 immunostaining in thyroid pathology. Ann Pathol. 2001;21:15-20.
-
(2001)
Ann Pathol
, vol.21
, pp. 15-20
-
-
Rigau, V.1
Martel, B.2
Evrard, C.3
-
66
-
-
0030611933
-
HBME-1 immunostaining in thyroid fine-needle aspirations: A useful marker in the diagnosis of carcinoma
-
Sack MJ, Astengo-Osuna C, Lin BT, et al. HBME-1 immunostaining in thyroid fine-needle aspirations: a useful marker in the diagnosis of carcinoma. Mod Pathol. 1997;10:668-674.
-
(1997)
Mod Pathol
, vol.10
, pp. 668-674
-
-
Sack, M.J.1
Astengo-Osuna, C.2
Lin, B.T.3
-
67
-
-
0038333426
-
HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm
-
Mase T, Funahashi H, Koshikawa T, et al. HBME-1 immunostaining in thyroid tumors especially in follicular neoplasm. Endocrinol J. 2003;50:173-177.
-
(2003)
Endocrinol J
, vol.50
, pp. 173-177
-
-
Mase, T.1
Funahashi, H.2
Koshikawa, T.3
-
68
-
-
0035053094
-
Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer
-
Ringel MD, Anderson J, Souza SL, et al. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod Pathol. 2001;14:289-296.
-
(2001)
Mod Pathol
, vol.14
, pp. 289-296
-
-
Ringel, M.D.1
Anderson, J.2
Souza, S.L.3
-
69
-
-
0034966198
-
Expression of sodium iodide symporter in benign and malignant human thyroid tissues
-
Lin JD, Hsueh C, Chao TC, et al. Expression of sodium iodide symporter in benign and malignant human thyroid tissues. Endocrinol Pathol. 2001;12:15-21.
-
(2001)
Endocrinol Pathol
, vol.12
, pp. 15-21
-
-
Lin, J.D.1
Hsueh, C.2
Chao, T.C.3
-
70
-
-
0036162543
-
Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis
-
Cornetta AJ, Russell JP, Cunnane M, et al. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis. Laryngoscope. 2002;112:238-242.
-
(2002)
Laryngoscope
, vol.112
, pp. 238-242
-
-
Cornetta, A.J.1
Russell, J.P.2
Cunnane, M.3
-
71
-
-
12244288609
-
An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for COX-1 and COX-2 enzymes
-
Bell CD, Vidal S, Kovacs K, et al. An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for COX-1 and COX-2 enzymes. Endocrinol Pathol. 2002;13:331-340.
-
(2002)
Endocrinol Pathol
, vol.13
, pp. 331-340
-
-
Bell, C.D.1
Vidal, S.2
Kovacs, K.3
-
72
-
-
0036223733
-
Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections
-
Moritani S, Kushima R, Sugihara H, et al. Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol. 2002;15:397-405.
-
(2002)
Mod Pathol
, vol.15
, pp. 397-405
-
-
Moritani, S.1
Kushima, R.2
Sugihara, H.3
-
73
-
-
0036329227
-
Stromal expression of CD10 in invasive breast carcinoma: A new predictor of clinical outcome
-
E-pub April 13, 2002
-
Iwaya K, Ogawa H, Izumi M, et al. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome. Virchows Arch. 2002;440:589-593. (E-pub April 13, 2002.)
-
(2002)
Virchows Arch
, vol.440
, pp. 589-593
-
-
Iwaya, K.1
Ogawa, H.2
Izumi, M.3
-
74
-
-
0036916550
-
Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma
-
Lau SK, Prakash S, Geller SA, et al. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma. Hum Pathol. 2002;33:1175-1181.
-
(2002)
Hum Pathol
, vol.33
, pp. 1175-1181
-
-
Lau, S.K.1
Prakash, S.2
Geller, S.A.3
-
75
-
-
0042660993
-
CD10 and calretinin staining of endocervieal glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma
-
McCluggage WG, Oliva E, Herrington CS, et al. CD10 and calretinin staining of endocervieal glandular lesions, endocervical stroma and endometrioid adenocarcinomas of the uterine corpus: CD10 positivity is characteristic of, but not specific for, mesonephric lesions and is not specific for endometrial stroma. Histopathology. 2003;43:144-150.
-
(2003)
Histopathology
, vol.43
, pp. 144-150
-
-
McCluggage, W.G.1
Oliva, E.2
Herrington, C.S.3
-
76
-
-
0037364291
-
CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma
-
Tomoda C, Kushima R, Takeuti E, et al. CD10 expression is useful in the diagnosis of follicular carcinoma and follicular variant of papillary thyroid carcinoma. Thyroid. 2003;13:291-295.
-
(2003)
Thyroid
, vol.13
, pp. 291-295
-
-
Tomoda, C.1
Kushima, R.2
Takeuti, E.3
-
77
-
-
0028334511
-
Differentiation of thyroid neoplasms by evaluating epithelial membrane antigen, Leu-7 antigen, epidermal growth factor receptor, and DNA content
-
Cheifetz RE, Davis NL, Robinson BW, et al. Differentiation of thyroid neoplasms by evaluating epithelial membrane antigen, Leu-7 antigen, epidermal growth factor receptor, and DNA content. Am J Surg. 1994; 167:531-534.
-
(1994)
Am J Surg
, vol.167
, pp. 531-534
-
-
Cheifetz, R.E.1
Davis, N.L.2
Robinson, B.W.3
-
78
-
-
0026542522
-
Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: Its usefulness as a diagnostic marker for follicular and papillary carcinomas
-
Ghali VS, Jimenez EJ, Garcia RL. Distribution of Leu-7 antigen (HNK-1) in thyroid tumors: its usefulness as a diagnostic marker for follicular and papillary carcinomas. Hum Pathol. 1992;23:21-25.
-
(1992)
Hum Pathol
, vol.23
, pp. 21-25
-
-
Ghali, V.S.1
Jimenez, E.J.2
Garcia, R.L.3
-
79
-
-
0031802539
-
CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma
-
Khan A, Baker SR Patwardhan NA, et al. CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma. Virchows Arch. 1998;432:427-432.
-
(1998)
Virchows Arch
, vol.432
, pp. 427-432
-
-
Khan, A.1
Baker, S.R.2
Patwardhan, N.A.3
-
80
-
-
0028158654
-
Immunostaining for Leu-7 in the diagnosis of thyroid carcinoma
-
Loy TS, Darkow GV, Spollen LE, et al. Immunostaining for Leu-7 in the diagnosis of thyroid carcinoma. Arch Pathol Lab Med. 1994;118: 172-174.
-
(1994)
Arch Pathol Lab Med
, vol.118
, pp. 172-174
-
-
Loy, T.S.1
Darkow, G.V.2
Spollen, L.E.3
-
81
-
-
0029066387
-
Leu-7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms
-
Ostrowski ML, Brown RW, Wheeler TM, et al. Leu-7 immunoreactivity in cytologic specimens of thyroid lesions, with emphasis on follicular neoplasms. Diagn Cytopathol. 1995;12:297-302.
-
(1995)
Diagn Cytopathol
, vol.12
, pp. 297-302
-
-
Ostrowski, M.L.1
Brown, R.W.2
Wheeler, T.M.3
-
82
-
-
0031447594
-
Thyroid transcription factor-1
-
Bingle CD. Thyroid transcription factor-1. Int J Biochem Cell Biol. 1997;29:1471-1473.
-
(1997)
Int J Biochem Cell Biol
, vol.29
, pp. 1471-1473
-
-
Bingle, C.D.1
-
83
-
-
0030880728
-
Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/1- Symporter gene
-
Endo T, Kaneshige M, Nakazato M, et al. Thyroid transcription factor-1 activates the promoter activity of rat thyroid Na+/1- symporter gene. Mol Endocrinol. 1997;11:1747-1755.
-
(1997)
Mol Endocrinol
, vol.11
, pp. 1747-1755
-
-
Endo, T.1
Kaneshige, M.2
Nakazato, M.3
-
84
-
-
0029875197
-
Monoclonal antibody to thyroid transcription factor-1: Production, characterization, and usefulness in tumor diagnosis
-
Holzinger A, Dingle S, Bejarano PA, et al. Monoclonal antibody to thyroid transcription factor-1: production, characterization, and usefulness in tumor diagnosis. Hybridoma. 1996;15:49-53.
-
(1996)
Hybridoma
, vol.15
, pp. 49-53
-
-
Holzinger, A.1
Dingle, S.2
Bejarano, P.A.3
-
85
-
-
0032735512
-
Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression
-
Suzuki K, Mori A, Lavaroni S, et al. Thyroglobulin regulates follicular function and heterogeneity by suppressing thyroid-specific gene expression. Biochimie. 1999;81:329-340.
-
(1999)
Biochimie
, vol.81
, pp. 329-340
-
-
Suzuki, K.1
Mori, A.2
Lavaroni, S.3
-
86
-
-
0034000801
-
Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin
-
Westbury C, Vini L, Fisher C, et al. Recurrent differentiated thyroid cancer without elevation of serum thyroglobulin. Thyroid. 2000;10:171-176.
-
(2000)
Thyroid
, vol.10
, pp. 171-176
-
-
Westbury, C.1
Vini, L.2
Fisher, C.3
|